These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 28810295

  • 1. [Utility and evaluation of immunohistochemical detection of BRAF V600E mutation in melanoma].
    Lyu JJ, Kong YY, Cai X, Shen XX, Lu YW, Ren M.
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug 08; 46(8):548-552. PubMed ID: 28810295
    [Abstract] [Full Text] [Related]

  • 2. A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan.
    Huang WK, Kuo TT, Wu CE, Cheng HY, Hsieh CH, Hsieh JJ, Shen YC, Hou MM, Hsu T, Chang JW.
    Asia Pac J Clin Oncol; 2016 Dec 08; 12(4):403-408. PubMed ID: 27488807
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.
    Liu H, Li Z, Wang Y, Feng Q, Si L, Cui C, Guo J, Xue W.
    Pathol Int; 2014 Dec 08; 64(12):601-6. PubMed ID: 25359093
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
    Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, Kefford RF, von Deimling A, Scolyer RA.
    Am J Surg Pathol; 2013 Jan 08; 37(1):61-5. PubMed ID: 23026937
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas.
    Routhier CA, Mochel MC, Lynch K, Dias-Santagata D, Louis DN, Hoang MP.
    Hum Pathol; 2013 Nov 08; 44(11):2563-70. PubMed ID: 24071017
    [Abstract] [Full Text] [Related]

  • 7. Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma.
    Pearlstein MV, Zedek DC, Ollila DW, Treece A, Gulley ML, Groben PA, Thomas NE.
    J Cutan Pathol; 2014 Sep 08; 41(9):724-32. PubMed ID: 24917033
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
    Busam KJ, Hedvat C, Pulitzer M, von Deimling A, Jungbluth AA.
    Am J Surg Pathol; 2013 Mar 08; 37(3):413-20. PubMed ID: 23211290
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.
    Dvorak K, Higgins A, Palting J, Cohen M, Brunhoeber P.
    Pathol Oncol Res; 2019 Jan 08; 25(1):349-359. PubMed ID: 29127628
    [Abstract] [Full Text] [Related]

  • 11. [Immunohistochemistry using clone VE1 is an economic, specific and sensitive method for detecting the presence of BRAFV600E mutations in melanoma].
    Etienne M, Oca F, Prunier-Mirebeau D, Croué A, Martin L.
    Ann Dermatol Venereol; 2018 Mar 08; 145(3):159-165. PubMed ID: 29221650
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens.
    Løes IM, Immervoll H, Angelsen JH, Horn A, Geisler J, Busch C, Lønning PE, Knappskog S.
    Tumour Biol; 2015 Feb 08; 36(2):1003-13. PubMed ID: 25318602
    [Abstract] [Full Text] [Related]

  • 14. Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma.
    Zhu X, Luo Y, Bai Q, Lu Y, Lu Y, Wu L, Zhou X.
    Exp Mol Pathol; 2016 Feb 08; 100(1):236-41. PubMed ID: 26795218
    [Abstract] [Full Text] [Related]

  • 15. Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay.
    Vallée A, Denis-Musquer M, Herbreteau G, Théoleyre S, Bossard C, Denis MG.
    PLoS One; 2019 Feb 08; 14(8):e0221123. PubMed ID: 31415669
    [Abstract] [Full Text] [Related]

  • 16. VE1 immunohistochemistry is an adjunct tool for detection of BRAFV600E mutation: Validation in thyroid cancer patients.
    Rashid FA, Tabassum S, Khan MS, Ansari HR, Asif M, Sheikh AK, Sameer Aga S.
    J Clin Lab Anal; 2021 Feb 08; 35(2):e23628. PubMed ID: 33305405
    [Abstract] [Full Text] [Related]

  • 17. Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.
    Colomba E, Hélias-Rodzewicz Z, Von Deimling A, Marin C, Terrones N, Pechaud D, Surel S, Côté JF, Peschaud F, Capper D, Blons H, Zimmermann U, Clerici T, Saiag P, Emile JF.
    J Mol Diagn; 2013 Jan 08; 15(1):94-100. PubMed ID: 23159108
    [Abstract] [Full Text] [Related]

  • 18. BRAF(V600E) and NRAS(Q61L/Q61R) mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting.
    Kakavand H, Walker E, Lum T, Wilmott JS, Selinger CI, Smith E, Saw RP, Yu B, Cooper WA, Long GV, O'Toole SA, Scolyer RA.
    Histopathology; 2016 Oct 08; 69(4):680-6. PubMed ID: 27151331
    [Abstract] [Full Text] [Related]

  • 19. Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma.
    Rössle M, Sigg M, Rüschoff JH, Wild PJ, Moch H, Weber A, Rechsteiner MP.
    Virchows Arch; 2013 Nov 08; 463(5):623-31. PubMed ID: 24085553
    [Abstract] [Full Text] [Related]

  • 20. Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach.
    Lasota J, Kowalik A, Wasag B, Wang ZF, Felisiak-Golabek A, Coates T, Kopczynski J, Gozdz S, Miettinen M.
    Am J Surg Pathol; 2014 Sep 08; 38(9):1235-41. PubMed ID: 24832158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.